Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Cancer. 2010 May 1;116(9):2201–2207. doi: 10.1002/cncr.25005

Figure 1. Everolimus treatment resulted in an increase in the absolute lymphocyte count (ALC) and decrease in lymphadenopathy in 8 patients.

Figure 1

The maximum decrease in the clinically measurable lymphadenopathy (node size) is shown by the grey bars) and associated increase in the ALC by the black bars.